IP Due Diligence in Mergers: 5 Steps to Protect a Deal
A buy-side playbook for IP due diligence in mergers and acquisitions: how to verify ownership, surface encumbrances, review AI and data assets, and turn findings into deal terms.
Read MorePerspireIP Blog
Expert perspectives on intellectual property strategy, patent law, trademark protection, and IP portfolio management from the PerspireIP team.
A buy-side playbook for IP due diligence in mergers and acquisitions: how to verify ownership, surface encumbrances, review AI and data assets, and turn findings into deal terms.
Read MoreA practitioner's guide to setting, benchmarking and negotiating patent royalty rates in 2026, with real industry ranges, calculation methods and the clauses that protect your money.
Read MoreDescriptive trademarks can only reach the Principal Register by proving secondary meaning. Here are the seven kinds of evidence the USPTO and courts weigh under Section 2(f).
Read MoreA practical guide to the doctrine of equivalents: the two equivalence tests, the all-elements rule, and the limits that decide whether a near-miss product infringes.
Read MoreA patent term extension under 35 USC 156 can restore years a drug or device patent lost during FDA review. Here are the six rules that govern it.
Read MoreA Paris Convention priority claim links a later foreign filing back to your first application. Here are the seven rules that decide whether it survives.
Read MoreA PCT divisional application does not exist in the international phase. Here is how unity of invention really works and when to split out inventions.
Read MoreYour intent-to-use mark was allowed, not registered. The trademark statement of use is the final step that proves real use and turns allowance into a registration.
Read MoreYour patent is about to grant, but you want broader claims or room to chase competitors. A patent continuation application keeps the door open. Here's how to use it.
Read MoreThe examiner issued a restriction requirement and you elected one invention. A divisional patent application is how you keep the rest. Here are the rules that matter.
Read MoreMailing yourself a sealed copy of your work feels like cheap insurance. In court it is close to worthless. Here is what actually protects a creative work.
Read MoreTaking a PCT application into Europe means one route, one office, and one unforgiving 31-month deadline. Here is exactly what the EPO needs and when.
Read MoreOnce the EPO signals it intends to grant, a non-extendable four-month clock starts. Miss it and the application is deemed withdrawn. Here is exactly what to do.
Read MoreYour company doesn't automatically own what your employees invent. An invention assignment agreement is what makes ownership stick, if you draft it correctly.
Read MoreA utility model can protect your product in months for a fraction of a patent's cost, but it comes with real trade-offs. Here is when each one wins.
Read MoreA competitor's European patent application is heading for grant. You don't have to wait for opposition. Here is how EPO third-party observations work, and how to use them well.
Read MoreDisclosed your invention before filing? In the US you may still have time. Here is how the patent grace period works, where it fails, and how not to lose your rights.
Read MoreGrant is not the finish line in Europe. Here is how European patent validation works, the deadline you cannot miss, and how to keep translation costs under control.
Read MoreAn Examining Division refusal or an opposition loss is not the end. Here is how EPO appeal proceedings work, the deadlines that decide them, and how to win.
Read MoreA practical guide to the EPO divisional application: the pending deadline under Rule 36, the current 2026 rules, the back-renewal cost trap, and the added-matter and double-patenting pitfalls.
Read MoreLet our experts help you develop a comprehensive IP strategy tailored to your business needs.
Get Started Today